Erythrocyte-based Pig-a gene mutation assay.

Area of Science:

• Toxicology
• Genetics
• Biomedical Science

Background:

• Genotoxicity testing is crucial in preclinical safety evaluations.
• Assessing gene mutations complements chromosomal damage analysis.
• The Pig-a gene assay identifies loss-of-function mutations.

Purpose of the Study:

• To describe a method for assessing Pig-a gene mutations in red blood cells.
• To detail the collection, processing, and flow cytometric analysis of peripheral blood samples.
• To utilize MutaFlow® kits and standard flow cytometry for genotoxicity assessment.

Main Methods:

• The assay relies on the loss of cell surface protein expression due to Pig-a gene mutation.
• Flow cytometry is used to detect the altered cell surface phenotype in red blood cells.
• Peripheral blood samples are processed using MutaFlow® kits.

Main Results:

• The described procedure enables the assessment of red blood cell surface markers indicative of Pig-a mutation.
• Flow cytometry provides a quantitative measure of cells with the specific phenotype.
• The method is suitable for routine preclinical safety testing.

Conclusions:

• The Pig-a gene mutation assay is a valuable tool for genotoxicity testing.
• This flow cytometry-based method offers a reliable way to assess gene mutations.
• The procedure facilitates preclinical safety evaluations in drug development.